InvestorsHub Logo
Followers 134
Posts 7040
Boards Moderated 0
Alias Born 02/09/2012

Re: loanranger post# 363033

Saturday, 06/19/2021 2:13:22 PM

Saturday, June 19, 2021 2:13:22 PM

Post# of 403075
The statement:

"Cover up!" assertion should be given a rest until at least around the second week of July.



IS an understatement...and ALSO an obvious misrepresentation of the IPIX's RP as to when DATA MAY BE RELEASED (PER FDA PROTOCOL):

https://www.ipharminc.com/press-release/2021/6/3/innovation-pharma-completes-enrollment-in-phase-2-clinical-trial-for-covid-19

"Complete trial enrollment comprised 120 dosed patients recruited across multiple sites. Final data collection for [color=red]the last patient enrolled in the study is expected to occur in early August (Study Day 60), which will then be followed by the process of unblinding study data and the reporting of topline study results."



The data cannot be released...no less published, for 60 days after the last patient has completed the Brilacidin regime. (beginning of August)...at which time data will be released for analysis...analysis takes time...then comes the reporting of data and analysis)


Left out the comments was reference to the TOTAL FDA WAITING PERIOD OF 60 Days (inclusive of the 29-day patient follow-up):

"...How could they know the "Time to sustained recovery through Day 29" when for some patients Day 29 has yet to occur?"



Surely an oversight? LOL...

THIS IS A NON-ISSUE...and Data release timing is at this point a Strawman argument ... which has no basis for raising until August and then only after a reasonable time for analysis has passed, at which time analysis and data would be released.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News